Abstract
Certain cancers, particularly small cell lung cancer, gynaecological or breast and also testicular, prostate, bowel and other cancers, can be associated with diverse and often heterogeneous neurological syndromes. In those cases with neurological syndromes, a proportion of patients will have a serum antibody to a defined antigen that is expressed both by the tumour and by the nervous system. The presence of the neurological syndrome often precedes the recognition of the tumour, and thus the detection of one of the specific antibodies leads to a search for the relevant tumour. In general, the antibodies are detected by immunohistochemistry or immunofluorescence on brain tissue. Their specificity can then be confirmed either by western blotting of neuronal or brain extracts, or by western blotting of the specific recombinant protein. There are also some ELISA assays available for detection of antibodies to specific antigens.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vincent, A. Antibodies associated with paraneoplastic neurological disorders. Neurol Sci 26 (Suppl 1), s3–s4 (2005). https://doi.org/10.1007/s10072-005-0387-8
Issue Date:
DOI: https://doi.org/10.1007/s10072-005-0387-8